You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

Litigation Details for In re Novartis and Par Antitrust Litigation (S.D.N.Y. 2018)

✉ Email this page to a colleague

« Back to Dashboard

In re Novartis and Par Antitrust Litigation (S.D.N.Y. 2018)

Docket	⤷ Sign Up	Date Filed	2018-05-16
Court	District Court, S.D. New York	Date Terminated
Cause	15:1 Antitrust Litigation (Monopolizing Trade)	Assigned To	Alvin K. Hellerstein
Jury Demand	Plaintiff	Referred To
Patents	6,294,197; 6,395,728
Link to Docket	External link to docket

Small Molecule Drugs cited in In re Novartis and Par Antitrust Litigation

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for In re Novartis and Par Antitrust Litigation (S.D.N.Y. 2018)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2019-08-15	193	Memorandum & Opinion	of certain follow-on patents (U.S. Patent Nos. 6,294,197 ("the '197 Patent") and 6,395,728…Novartis' patents. Novartis owned U.S. Patent No. 5,399,578 ("the '578 patent), which covered…, 4, 77. The validity of this patent was not challenged. The patent expired on March 21, 20_12, and… to the patent holder, among others, and describe the basis for its position that the patent at issue…, "Novartis"), nearing the end of one patent covering their prescription drug, Exforge, a blood	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.